Amber, Khalid I <br/><br/>
Trimetazidine attenuates the acute inflammatory response induced by Novolimus eluting bioresorbable coronary scaffold implantation.  [electronic resource] 

 -  International journal of cardiology  Oct 2016 
 - 514-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2016.06.172  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorbable Implants--adverse effects<br/>Adult<br/>Aged<br/>Coronary Vessels--drug effects<br/>Drug-Eluting Stents--adverse effects<br/>Female<br/>Humans<br/>Inflammation--blood<br/>Inflammation Mediators--blood<br/>Macrolides--adverse effects<br/>Male<br/>Middle Aged<br/>Percutaneous Coronary Intervention--adverse effects<br/>Single-Blind Method<br/>Tissue Scaffolds--adverse effects<br/>Trimetazidine--administration & dosage<br/>Vasodilator Agents--administration & dosage